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A Multicenter Assessment of the Use of
Single-Photon Emission Computed Tomography
Myocardial Perfusion Imaging With Appropriateness Criteria
Robert C. Hendel, MD,* Manuel Cerqueira, MD,† Pamela S. Douglas, MD,‡
Karen C. Caruth,§ Joseph M. Allen, MA,§ Neil C. Jensen, MHA, MBA, Wenqin Pan, PHD,‡
Ralph Brindis, MD,¶ Michael Wolk, MD#
Winfield, Illinois; Cleveland, Ohio; Durham, North Carolina; Washington, DC; Minneapolis, Minnesota;
Oakland, California; and New York, New York
Objectives The aim of this study was to assess the feasibility of evaluation for appropriate use of radionuclide myocardial
perfusion imaging (MPI) in multiple clinical sites and to determine use patterns as well as identify areas of ap-
parent inappropriate use.
Background Although cardiac imaging is highly valued for decision-making, the growth and expense related to these proce-
dures has raised questions regarding overuse. The publication of appropriate use criteria (AUC), including those
for MPI, were designed to provide guidance in the rational use of testing. However, limited data regarding the
implementation and evaluation of AUC are available.
Methods Six diverse clinical sites enrolled consecutive patients undergoing MPI, collecting point-of-service data entered into an
online form. An automated algorithm assigned a specific indication from the AUC that was classified as appropriate,
uncertain, or inappropriate. Site-specific feedback was later provided to each practice on ordering patterns.
Results Of the 6,351 patients enrolled, 93% were successfully assigned an appropriateness level. Inappropriate use of MPI
was found in 14.4% of patients, with a range of 4% to 22% among practices. Women and younger patients were
more likely to undergo inappropriate MPI. Asymptomatic, low-risk patients accounted for 44.5% of inappropriate test-
ing. Elimination of the 5 most common inappropriate use indications would reduce overall imaging volume by 13.2%.
Inappropriate use by physicians from within the practice performing imaging was not greater than physicians outside
of the practice. Educational feedback might have resulted in reduced inappropriate test ordering in 1 site.
Conclusions The tracking of appropriate use is feasible in clinical practice, with an automated system that can readily iden-
tify practice patterns and targets for educational and quality improvement initiatives. This approach might pro-
vide an alternative to utilization management. (J Am Coll Cardiol 2010;55:156–62) © 2010 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.11.004p
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sardiac imaging is a mainstay in medical decision-making
or patients with known or suspected heart disease. How-
ver, expenditures related to imaging comprise a significant
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n March 29, 2009.T
Manuscript received August 19, 2009; revised manuscript received November 2,
009, accepted November 2, 2009.ortion of the health care budget (1–4). Much scrutiny has
een focused on cardiovascular imaging with regard to the
otential for overuse, especially in view of substantial
eographic variation in ordering patterns and the limited
mount of evidence-based data supporting the use of imag-
ng as it relates to patient outcomes (3,4). Furthermore,
nancial incentives and issues related to self-referral have
een suggested as explanations for the growth of cardiovas-
ular imaging (3–5).
See page 163
To address these use issues, appropriate use criteria
AUC) have been developed by several medical specialty
ocieties, including the American College of Cardiology.
his group began its focus on imaging use with the
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January 12, 2010:156–62 Appropriate Use for SPECT MPIublication of the AUC for single-photon emission com-
uted tomography (SPECT) myocardial perfusion imaging
MPI) in 2005, done in collaboration with the American
ociety of Nuclear Cardiology (6). Since then, AUC have
een developed for other cardiac imaging modalities (7–9)
s well as coronary revascularization (10). An updated
ersion of the AUC for radionuclide imaging was recently
ublished (11).
Clinical practice guidelines and AUC provide advice
egarding the use of technology and therapeutic interven-
ions to improve test selection and overall clinical care.
everal single-site evaluations of AUC for cardiovascular
maging have been performed but might not be readily
pplicable to community clinical practices (12–16). There-
ore, a collaborative prospective effort was undertaken by the
merican College of Cardiology Foundation (ACCF) and
nitedHealthcare (UHC), featuring an automated, objec-
ive method with the ACCF Appropriateness Criteria for
PECT MPI. The goals of this pilot study were to: 1)
evelop a process and data collection tool to evaluate the
ppropriateness of SPECT MPI testing; 2) implement the
rocess and tool at the point-of-imaging-service in a variety
f outpatient settings; 3) determine the rate of appropriate,
ncertain, and inappropriate SPECT MPI studies; 4) de-
elop feedback mechanisms to improve adherence to AUC;
nd 5) assess change in practice patterns over time.
ethods
ite selection. Sites were selected from a list of locations
erforming at least 200 SPECT MPI studies for UHC
embers annually in community-based group practices.
ospital-based groups and practices with more than 50
hysicians were excluded. Sites were selected by the inves-
igators on the basis of diverse practice sizes, geographic
ocation, and settings (urban, suburban, rural) as well as
erformance of an average total volume of 60 SPECT
tudies/month for all payers. Practices signed a letter of
greement outlining the terms for data collection. In ex-
hange for participation, each practice was granted an
xemption from prior authorization for cardiac imaging for
HC patients and received an unrestricted grant for par-
icipation in the pilot to cover administrative expenses.
ocal institutional review board approval for the study was
btained at each site.
ata collection. Data were collected for all patients receiv-
ng a SPECT study in a consecutive fashion, irrespective of
ealth plan coverage. Sites had staggered enrollment and
erminated their participation at varying times throughout
he course of the pilot. Information was obtained at the
oint-of-service (i.e., where the SPECT MPI test was being
erformed). Exercise physiologists, nurses, advanced prac-
itioners, and physicians recorded clinical information on a
rief, 2-page data collection form, which was then trans-
erred to a web-based instrument that mirrored the data collection form. The information
ntered online was centralized
nto a relational database. Alter-
atively, practitioners or admin-
strative personnel could enter
ata directly onto the online data
ntry tool via the pilot website,
hich was securely housed at
CCF headquarters. Collected
ata elements included patient
emographic information, medi-
al history, risk assessment, and
nformation regarding prior car-
iovascular procedures, such as
evascularization and imaging
rocedures. UHC and its em-
loyees were not involved in the
ata collection, analysis, report-
ng of the results, or drafting of
his report.
ppropriate use determination. Computer-based logic
as used to assign each patient a specific indication on the
asis of the previously published SPECT MPI appropriate-
ess criteria (6), thereby permitting categorization of each
can as appropriate, uncertain, inappropriate, or unclassifi-
ble. This was done in a hierarchical fashion, similar to that
reviously reported (13). Dyspnea was considered as an
nginal equivalent and was categorized as “atypical chest
ain.” To estimate Framingham risk, assumptions were
ade related to the use of medications, with the following
onclusions: patients receiving statins were categorized as
aving hyperlipidemia; those in antihypertensive medica-
ions were classified as hypertensive, and so forth.
eports/site feedback. Approximately 6 months after
tudy initiation, reports of appropriate, uncertain, and in-
ppropriate testing rates were made available online in a
eal-time fashion at each site (“on-demand reporting”)
hould sites choose to access it. A summary report was also
repared and distributed to each site and to UHC. This
eport provided summary data for the sites on their perfor-
ance, the most frequent appropriate and inappropriate
ndications for SPECT MPI, and also provided a blinded
omparison with the performance of the other sites.
Feedback from the sites on data collection and use of the
ata was obtained via telephone calls throughout the study.
ducational initiatives. In addition to the summary re-
orts, each practice was informed of detailed indications for
nappropriate ordering of SPECT occurring at their site.
ites were also sent a sample letter that could be used as an
ducational tool for referring physicians about common
easons for ordering inappropriate tests. Pocket cards pro-
iding risk screening criteria and a list of the most common
nappropriate indications were also provided.
tatistical methods. Contingency tables were generated to
xplore the relationships between appropriateness classifi-
Abbreviations
and Acronyms
ACCF  American College
of Cardiology Foundation
AUC  appropriate use
criteria
CAD  coronary artery
disease
CHD  coronary heart
disease
MPI  myocardial perfusion
imaging
PCI  percutaneous
coronary intervention
SPECT  single-photon
emission computed
tomography
UHC  UnitedHealthcareation and patient demographic information, symptoms,
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Appropriate Use for SPECT MPI January 12, 2010:156–62isk factors, practice locale, and whether the patient referrals
ame from within the practice or from physicians not
elonging to the practice performing the SPECT study.
earson chi-square test for nominal data and Kruskal-
allis tests for ordinal and continuous data were used as
ests for statistical associations. Inappropriateness rates were
ested and compared across sites or over time with Pearson
hi-square test or Cochran-Mantel-Haenszel test. Multiva-
iable logistic regression models were performed to deter-
ine the independent covariates associated with patients
eceiving inappropriate scans. The generalized estimating
quation approach was used to account for within-practice
lustering. Due to the high rate of missing data for deter-
ination of CHD risk (17%), a multiple imputation tech-
ique was applied to the observed data to avoid bias in the
egression analysis. This method is widely accepted for
atasets with missing values (17). All statistical analyses
ere performed with SAS version 9.1 software (SAS Insti-
ute, Cary, North Carolina).
esults
tudy sites and enrollment. Enrollment of subjects lasted
year, on a rolling basis, from March 1, 2008, to until
ebruary 28, 2009. Three time periods were identified
uring the study: 1) before any report availability (before
ugust 16, 2008), when no feedback or tracking informa-
ion regarding practice patterns was available; 2) after
vailability of on-demand reporting (August 16, 2008, to
ctober 14, 2008); and 3) after the distribution of formal,
enchmarked site-specific, and overall study performance
eports (after October 15, 2008).
Six sites participated in this pilot study; 3 urban, 2
uburban, and 1 rural location. Practices were located in
lorida, Wisconsin, Oregon, and Arizona, and the number
f cardiologists at each site ranged from 7 to 20 physicians.
he number of SPECT MPI patients submitted from each
ite varied from 328 to 1,597 patients. Sites reported that
ata entry required 5 to 10 min/patient.
atient characteristics. A total of 6,351 subjects with com-
lete data were entered into the pilot database (Table 1).
isk factors were common—hypertension (76.7%), hyper-
ipidemia (72.9%), diabetes (22.8%). A history of coronary
evascularization (coronary artery bypass graft surgery or
CI) was present in 47.5% of patients. Table 1 presents the
isk categories for patients without documented coronary
rtery disease (CAD). Among such patients, the pre-test
ikelihood of disease (18) was very low (5%) in 6.0%, low
5% to 10%) in 34.7%, moderate (10% to 90%) in 54.0%,
nd high (90%) in 5.3%. The CHD risk data are also
resented for patients without CAD; these data are similar
o the cohort of asymptomatic patients without known
AD (n 953), whose risk was assessed with the Framing-
am risk criteria (19), demonstrating that 68.3% of patients
ere at low risk, with moderate and high risk noted in 9.5%nd 22.1% subjects, respectively. (Exercise SPECT imaging was performed in 54.0% of the
ubjects, with pharmacologic stress used in 43.9%; the
emaining 2.1% had a combination of pharmacologic and
xercise stress.
ppropriate use determination. The level of appropriate-
ess was not able to be determined in 423 (6.7%) patients
Fig. 1A). The primary reason, accounting for 75.6% of
hese unclassified patients (n  320), was incomplete data
hat precluded the calculation of risk or a missing date of
evascularization, because the time since revascularization is
n important determinant of appropriateness in asymptom-
tic individuals. An additional 85 patients qualified for more
han 1 indication, such as patients that had both prior
oronary artery bypass graft surgery and prior PCI. Finally,
8 patients had incorrect test dates or incomplete records.
hen the unclassifiable studies were eliminated from the
nalysis, evaluable subjects (n  5,928) demonstrated ap-
ropriate use in 70.7% of cases, uncertain level of appropri-
teness in 14.9%, and inappropriate use in 14.4% of cases
Fig. 1B). Practice variation in inappropriate use ranged
rom 4.0% to 22.2%. However, significant differences in
ost patient-related factors, including age, sex, and risk
actors, were present among the 6 study sites.
actors affecting appropriateness category. Inappropriate
PECT MPI testing was performed more often in patients
ounger than 65 years of age (18.2% vs. 9.0%; p  0.0001).
nappropriate testing was also more common in women
atient Characteristics (n  6,351)Table 1 Patient Characteristics (n  6,351)
Age, yrs (mean  SD) 65.7 11.8
Men 3,729 (58.7%)
Diabetes 1,446 (22.8%)
Current smoker 743 (11.7%)
On lipid-lowering treatment 4,616 (72.9%)
On antihypertensive treatment 4,856 (76.7%)
History of PCI 1,806 (36.1%)
History of CABG 945 (19.7%)
Asymptomatic 2,414 (38.0%)
Stable chest pain 1,219 (19.2%)
Worsening chest pain 1,390 (21.9%)
Dyspnea 1,325 (20.9%)
Pre-test likelihood of CAD*
Very low 226 (6.0%)
Low 1,313 (34.7%)
Intermediate 2,039 (53.8%)
High 201 (5.3%)
Unclassified 10 (0.3%)
CHD risk†
Low 2,110 (55.7%)
Moderate 231 (6.1%)
High 635 (16.8%)
Unclassified 813 (21.5%)
ata are presented as n (%), unless otherwise specified. *Probability of coronary artery disease
CAD) on the basis of automated algorithm (18); determined in patients without known CAD.
10-year coronary heart disease (CHD) risk on the basis of automated algorithm (19); determined
n patients without known CAD only.
CABG  coronary artery bypass graft surgery; PCI  percutaneous coronary intervention.14.5%) than in men (12.6%; p  0.039). Among those
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January 12, 2010:156–62 Appropriate Use for SPECT MPIymptomatic patients without a prior diagnosis of CAD,
ery-low- or low-risk pre-test probability of CAD was
ssociated with inappropriateness rates of 49.0% and 35.3%,
espectively. Similarly, asymptomatic patients without
Figure 1
Assignment of Levels of
Appropriate Use From Patients
Collected During the Entire Enrollment Period
(A) All enrolled patients; (B) in evaluable patients.
Figure 2
Rate of Inappropriate Use in Patients
Without Known Coronary Artery Disease, on the
Basis of the Level of CHD Risk and if Asymptomatic
The majority of patients at low coronary heart disease (CHD) risk who had an
inappropriate designation were asymptomatic (n  409 of 493).rnown CAD who were at low CHD risk had a 63.0%
ncidence of inappropriate SPECT MPI, compared with
ates of 1.1% and 6.8% for intermediate- and high-risk
atients, respectively (Fig. 2).
Multivariate analysis revealed that asymptomatic status
as the best predictor of an inappropriate classification,
ncreasing the odds by 22-fold (Table 2). Sex was also an
ndependent factor, increasing the likelihood of being con-
idered inappropriate by 2.5 times for women compared
ith men, even when controlling for risk factors and
ymptoms. Among patients without known CAD, low
HD risk or a low pre-test likelihood for CAD were most
redictive of an inappropriate use of SPECT MPI.
A comparison of appropriateness between tests ordered
y cardiologists (n  4,792) and noncardiologists (n 
,136) noted a higher rate of inappropriate studies ordered
y noncardiologists (19.5% vs. 13.2%; p  0.0001). A
imilar analysis comparing the source of referral from within
he practice (n  4,881) compared with an external referral
n  1,047) revealed a higher rate of inappropriate test
rdering from outside of the practice (20.1% vs. 13.2%; p 
.0001). Of note, individual physicians within the practice
rdered approximately 5 times the number of SPECT MPI
tudies as the “outside” referring doctors.
linical indications. The 3 most common causes for
esting overall were all considered appropriate, including: 1)
valuation of chest pain syndrome after revascularization
ultivariate (Adjusted) Analysis ofac ors Relate to Inappropriate Use of SPECTTable 2 Multivari te (Adjusted) Analysis ofFactors Related to Inappropriate Use of SPECT
Variable OR 95% CI p Value
Entire cohort
Asymptomatic 22.5 15.2–33.2 0.0001
Women 2.5 2.2–2.9 0.0001
Diabetes 0.4 0.4–0.5 0.0001
Age* 0.5 0.4–0.6 0.0001
Lipid-lowering therapy 0.6 0.6–0.7 0.0001
Smoking 0.8 0.7–1.0 0.0178
Antihypertensive therapy 0.8 0.7–1.1 0.1676
Referral within practice 0.8 0.5–1.2 0.3115
Cardiologist referral 0.9 0.5–1.4 0.5680
Patients without CAD
Asymptomatic 3.2 1.4–7.2 0.0039
Women 1.3 1.1–1.6 0.006
Age* 0.8 0.6–0.9 0.0017
Lipid-lowering therapy 1.0 0.8–1.4 0.8667
Smoking 0.8 0.6–1.2 0.3576
Antihypertensive therapy 0.9 0.7–1.3 0.7138
Within practice 0.9 0.2–3.3 0.8575
Cardiologist 0.9 0.2–3.4 0.8779
Pre-test likelihood of CAD† 0.04 0.01–0.10 0.0001
CHD risk‡ 0.1 0.09–0.20 0.0001
Risk on the basis of 10-year intervals. †Pre-test likelihood of ischemic heart disease (18). The
omparison is between intermediate and high risk versus very low or low risk. ‡CHD risk was
etermined by the Framingham Risk score (19); this comparison was between moderate or high
isk versus low risk.
CI  confidence interval; OR  odds ratio; SPECT  single-photon emission computed tomog-
aphy; other abbreviations as in Table 1.
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Appropriate Use for SPECT MPI January 12, 2010:156–6219.5% of all cases); 2) evaluation of chest pain syndrome in
patient with intermediate pre-test probability of CAD and
ither unable to exercise or with an uninterpretable electro-
ardiogram (19.0%); and 3) evaluation of chest pain syn-
rome in a patient with intermediate probability of CAD
ho was able to exercise and had an interpretable electro-
ardiogram (9.6%). Table 3 shows the 5 most common
nappropriate indications, which alone accounted for 92.0%
f all inappropriate testing. These 5 inappropriate indica-
ions also account for 13.2% of all SPECT MPI testing.
cross all 6 sites, the most common inappropriate indica-
ion was for the detection of CAD in asymptomatic patients
ho were at low risk of CHD. At 5 of the 6 sites, the second
ost frequent inappropriate indication was the performance
f SPECT imaging 2 years after PCI in an asymptomatic
atient. This indication accounted for 23.8% of all inappro-
riate tests.
emporal patterns of appropriateness. Due to the stag-
ered initiation and termination of the study, only 4 of the
practices had sufficient data to examine rates of inappro-
riate testing during all 3 time periods: 1) before receiving
ny reports, representing baseline patterns of care; 2) vol-
ntary access to on-demand reports; and 3) after receiving
ritten report of practice performance and other educa-
ional materials. Only 1 of these sites had decreased inap-
ropriate testing, whereas the others did not. Please see
igure 3 for rates of inappropriate testing rates across time.
ost sites chose not to actively review their testing appro-
riateness and did not attempt to hold educational sessions
or ordering physicians. The single site that had a substan-
ial change in the rate of inappropriate test use initiated an
nternal analysis of appropriateness data and held group
eetings and discussions to educate physicians on compli-
nce with the AUC. The management team at this practice
as highly motivated to improve performance and made
ducation of physicians a priority; their inappropriate testing
ate was the highest of all the sites at baseline and decreased
ost Frequent Inappropriate IndicationsTable 3 Most Frequent Inappropriate Indications
Indication
Inappropriate
Studies, %
% of Total
Studies
Detection of CAD 44.5 6.4
Asymptomatic, low CHD risk*
Asymptomatic, post-revascularization 23.8 3.4
2 yrs after PCI, symptoms before PCI
Evaluation of chest pain, low probability 16.1 2.3
Interpretable ECG and able to exercise
Asymptomatic/stable symptoms, known
CAD 1 yr after catheterization or
abnormal prior SPECT
3.9 0.6
Pre-operative assessment 3.7 0.5
Low-risk surgery
Total† 92.0 13.2
CHD risk was determined by the Framingham Risk score (19). †The remaining 8% of inappropri-f
te studies are contained among the remaining inappropriate indications.
ECG  electrocardiogram; other abbreviations as in Tables 1 and 2.rom 22.0% (40 of 182) to 13.3% (34 of 256) at the end of
tudy (p  0.04).
iscussion
his pilot study is unique in that the evaluation of the
ppropriateness of SPECT MPI was done prospectively in
real-world” settings. Furthermore, the assignment of ap-
ropriateness category was done with an automated tool,
hich required a limited amount of data entry. The results
f this investigation demonstrate that it is feasible to track
atterns of SPECT MPI use in the standard workflow of
ontemporary clinical practice. The majority of tests were
ssigned to a designated level of appropriateness with an
bjective automated computer algorithm.
The appropriateness of SPECT MPI use was high,
ecause only 14.4% of studies were deemed inappropriate,
imilar to single site reports in academic settings of 13% to
4% (12,13). However, there was significant variation across
ur community-based sites, with inappropriate studies rang-
ng from 4% to 22% of SPECT examinations, which might
e related to varying use by physicians of evidence-based
uidelines and AUC. However, patient factors are likely
art of the explanation, given that differences in patient
haracteristics and overall risk were present among the sites.
The most common indications for inappropriate testing
ith SPECT MPI were well-defined and similar to those
oted in other publications (12,13). The identification of
hese high-impact areas for potential improvement is criti-
al, because these are specific foci where educational efforts
ight be directed. Because 5 indications accounted for more
han 90% of inappropriate testing, reduction or elimination
f these procedures could result in an overall decrease in
PECT MPI volume of up to 13%. In contrast to broad-
ased reimbursement cuts or use management, this selective
pproach to reducing procedural volume is less likely to
estrict access to testing among patients who might benefit
Figure 3 Rate of Inappropriate Studies for Each of the 4
Sites With Data for the 3 Time Periods of the Study
Period 1, baseline; Period 2, after availability of “on-demand”
reports; and Period 3, after delivery of specific site and aggregate reports.rom SPECT MPI.
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January 12, 2010:156–62 Appropriate Use for SPECT MPIAge and sex-related differences in appropriate use of
PECT were noted even after adjustment for comorbidi-
ies—similar to the study by Mehta et al. (12)—because
omen more often underwent inappropriate testing, as did
atients younger than 65 years of age. Not surprisingly,
atients with a very low or low likelihood of CAD or who
ad a low CHD risk were far more likely to have SPECT
PI designated as inappropriate, because the determination
f appropriateness category is largely risk-based.
No clear pattern of temporal factors regarding appropri-
te use of SPECT was noted. However, this is likely due to
any factors, including the staggered initiation of recruit-
ent at each site and the limited educational interventions
rovided at the sites, with poor dissemination of reports at
everal practices. The reduction in appropriateness rate at
ne of the sites that did embrace a practice-changing
nitiative around appropriateness is anecdotal and not a
efinitive demonstration of the effectiveness of their quality
ssurance program. However, it does demonstrate that a
igh level of commitment to quality improvement can result
n a reduction of the rate of inappropriate studies. This
xperience suggests that improving imaging practice pat-
erns with AUC might be feasible.
Self-referral has been cited as a primary reason for the
xplosive growth rate in cardiac imaging (3–5), but minimal
ata are available in support of this notion. Although not
ndependent predictors of inappropriate testing, data from
his pilot study demonstrate more inappropriate SPECT
PI ordering by physicians outside of the practice that
erforms the imaging study. The contribution to inappro-
riate use might be greater in those who lack financial
elf-incentive as compared with those who might have a
onflict, and that overall volume of tests ordered was not
elated to higher levels of inappropriate use. Noncardiolo-
ists order at least as many inappropriate SPECT MPI,
uggesting a need for education to referring physicians
utside of cardiology as well as use of a point-of-order
ecision tool to guide appropriate testing. The overall low
olume of tests ordered by each external referring physician
ight partially account for the high inappropriateness rates,
erhaps due to a lack of familiarity with current guidelines
nd appropriateness criteria.
tudy limitations. Although much thought and effort
ent into the development of the SPECT AUC (6), this
ork was the first effort by the American College of
ardiology and other collaborating organizations to define
he appropriate use of cardiac imaging procedures and as
uch might contain methodologic and/or interpretative
nadequacies. Hence, the assessment of appropriateness can
nly be as good as the current AUC standards. Although
he specific clinical indications were rated on the basis of
xpert opinion to develop the document, both indication
riting and rating is intentionally based upon relevant
edical published reports and existing practice guidelines.
n the absence of a high level of evidence for many
ndications, AUC do rely on expert opinion, as do the smerican College of Cardiology/American Heart Associa-
ion guidelines (20).
Nonevaluable data due to missing information or the
resence of multiple potential indications for the same case
ed to a designation of “unclassified” in some patients. The
olling recruitment periods prevented a consistent time
ourse for feedback and education. The educational efforts
rovided to practices were nonstandardized, leading to
otential differing degrees of penetration into clinical prac-
ice. The assignment of appropriateness score might be
roblematic; however, the computer algorithm developed
or this pilot study is automated and therefore objective and
hould avoid problems with interobserver variability, as
oted in a prior study (13). Furthermore, the potential risk
or misassignment of indications has been specifically ad-
ressed in the recent publication of the revised AUC for
adionuclide imaging, which has hierarchical features and is
lgorithm-based (11). Finally, our findings are specific for
he population and sites during the period of the study, and
o data are currently available regarding whether the assign-
ent of “appropriate” or “inappropriate” designations per
he AUC document itself (6) is correct. Studies capturing
he appropriateness of test ordering in the real world, such
s the present report, are a necessary first step in the process
f validating AUC, and future studies examining outcome
ata will help to resolve this issue.
tudy implications. Tracking practice performance in the
se of medical imaging, such as with SPECT MPI, is
easible and might enhance efficiency with well-defined and
arefully constructed AUC and a transparent, automated
mplementation approach. The patterns of inappropriate
se documented in this study provide clear pathways for
uality improvement and educational strategies and a foun-
ation for a new type of quality metric in imaging, one that
ight be used in regulatory decision-making, including
aboratory accreditation. Furthermore, these data suggest
hat clinicians should evaluate the pre-test likelihood for
schemic heart disease or the 10-year coronary heart disease
isk when SPECT MPI is being considered.
onclusions
he current health care environment continues to focus on
esource use. Physicians, medical societies, policymakers,
nd payers can collaborate on potential solutions for medical
maging, optimizing quality and preserving patient access,
ut in a cost-conscious fashion. The implementation of
UC permits a targeted approach and is both feasible and
as the potential to reduce over-use, with an emphasis on
eedback and education. This pilot study suggests an alter-
ative approach to traditional utilization management and
as potential for widespread application.
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APPENDIX
or a supplementary table on the frequency of indications, please see the
nline version of this article.
